胡桃醌对人卵巢癌SKOV3和IOSE80细胞增殖和侵袭的抑制作用及其机制研究

doi:10.12092/j.issn.1009-2501.2019.01.006

摘要/Abstract

摘要：

目的: 研究胡桃醌对人卵巢癌SKOV3和IOSE80细胞增殖和侵袭的抑制作用，并从信号通路深入探讨其作用机制。方法: 体外培养人卵巢癌SKOV3细胞和IOSE80细胞，给予不同浓度的胡桃醌溶液干预，MTT比色法检测细胞增殖，划痕实验检测细胞迁移，Transwell检测细胞转移，流式细胞术检测细胞凋亡，Western Blot检测AKT、ERK、NF-κB信号通路蛋白表达，RT-PCR检测波形蛋白(vimentin)、基质金属蛋白酶-2（MMP-2）、基质金属蛋白酶-9（MMP-9）mRNA表达。结果: 不同浓度胡桃醌可抑制SKOV3细胞和IOSE80细胞增殖活力，降低细胞侵袭能力，加速细胞凋亡，且随浓度的增加对细胞增殖、侵袭和凋亡的作用越明显，差异均有统计学意义（P<0.05）。不同浓度胡桃醌均可抑制SKOV3细胞和IOSE80细胞AKT、ERK、NF-κB信号通路蛋白的表达，且随浓度的增加信号通路蛋白表达减少，差异均有统计学意义（P<0.05）。不同浓度胡桃醌均可减少SKOV3细胞和IOSE80细胞Vimentin、MMP-2、MMP-9 mRNA的表达，且随浓度的增加mRNA表达减少，差异均有统计学意义（P<0.05）。结论: 胡桃醌可抑制SKOV3和IOSE80细胞体外增殖、转移，促进凋亡，其机制与抑制AKT、ERK、NF-κB信号通路表达和下调Vimentin、MMP-2、MMP-9 mRNA表达有关。

关键词: 人卵巢癌SKOV3细胞, 胡桃醌, 细胞增殖, 侵袭, 信号通路

Abstract:

AIM: To study the effect of juglone on proliferation and invasion of human ovarian cancer SKOV3 and IOSE80 cells, and to explore its mechanism through signal pathway. METHODS: Cells were cultured in vitro and treated with different concentrations of juglone. The cell proliferation was detected by MTT colorimetry, the cell migration was detected by scratch test, the cell metastasis was detected by Transwell, and the apoptosis was detected by flow cytometry. The protein expression of AKT, ERK, NF-κB signaling pathway were detected by Western blot, and the expressions of Vimentin, MMP-2 and MMP-9 mRNA were detected by RT-PCR. RESULTS: Different concentrations of juglone could inhibit the proliferation of SKOV3 and IOSE80 cells, reduce the invasive ability of cells, and accelerate the apoptosis, with increase of concentration the effect on cell proliferation, invasion and apoptosis were more obvious, the difference was statistically significant (P<0.05). The expressions of AKT, ERK and NF-κB signaling pathway proteins in SKOV3 and IOSE80 cells were decreased by different concentrations of juglone, and the expression decreased with the increase of concentration, the difference was statistically significant (P<0.05). The expressions of Vimentin, MMP-2 and MMP-9 mRNA in SKOV3 and IOSE80 cells were decreased with the increase of concentration of juglone, and the difference was statistically significant (P<0.05). CONCLUSION: Juglone can inhibit the proliferation and metastasis of SKOV3 and IOSE80 cells in vitro and promote apoptosis. The mechanism maybe related to inhibit the expression of AKT, ERK, NF-κB signaling pathway, downregulate of the expression of Vimentin, MMP-2 and MMP-9 mRNA.

Key words: human ovarian cancer SKOV3 cells, juglone, cell proliferation, invasion, signal pathway

中图分类号:

R711.1
R733

孙红亚，袁爱娟，李纪鹏. 胡桃醌对人卵巢癌SKOV3和IOSE80细胞增殖和侵袭的抑制作用及其机制研究[J]. 中国临床药理学与治疗学, 2019, 24(1): 32-37.

SUN Hongya, YUAN Aijuan, LI Jipeng. Inhibitory effect of juglone on proliferation and invasion of human ovarian cancer SKOV3 and IOSE80 cells and its mechanism[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(1): 32-37.

参考文献

［1］Grisham RN. Low-grade serous ovarian cancer: current treatment paradigms and future directions［J］. Curr Treat Options Oncol, 2018,19(11):54.
［2］Chen J, Jia Y, Jia ZH, et al. Silencing the expression of MTDH increases the radiation sensitivity of SKOV3 ovarian cancer cells and reduces their proliferation and metastasis［J］. Int J Oncol, 2018, 53(5):2180-2190.
［3］Ma Y, Xu Y. SPARCL1 suppresses the proliferation and migration of human ovarian cancer cells via the MEK/ERK signaling［J］. Exp Ther Med, 2018, 16(4):3195-3201.
［4］Li X, Bao C, Ma Z, et al.Perfluorooctanoic acid stimulates ovarian cancer cell migration, invasion via ERK/NF-κB/MMP-2/-9 pathway［J］. Toxicol Lett,2018,294(9):44-50.
［5］Mortensen JH, Godskesen LE, Jensen MD, et al. Fragments of citrullinated and MMP-degraded vimentin and MMP-degraded type III collagen are novel serological biomarkers to differentiate crohn's disease from ulcerative colitis［J］. J Crohns Colitis, 2015, 9(10):863-872.
［6］王添敏,俞文婕,邸学,等. 加入胡桃醌与敲除胡桃醌的胡桃楸水提物的抗肿瘤活性［J］.西北药学杂志,2017,32(4):480-485.
［7］Lu Z, Chen H, Zheng XM. Experimental study on the apoptosis of cervical cancer Hela cells induced by juglone through c-Jun N-terminal kinase/c-Jun pathway［J］. Asian Pac J Trop Med, 2017, 10(6):572-575.
［8］方芳,赵良中,李强,等. 胡桃醌对卵巢癌SKOV3细胞氧化应激和凋亡的影响［J］.中国病理生理杂志,2016,32(1):156-159.
［9］Moore KN. Administration of the Tablet Formulation of Olaparib in Patients with Ovarian Cancer: Practical Guidance and Expectations［J］. Oncologist, 2018,23(6):697-703.
［10］Di Lorenzo G, Ricci G, Severini GM, et al. Imaging and therapy of ovarian cancer: clinical application of nanoparticles and future perspectives［J］.Theranostics,2018,8(16):4279-4294.
［11］李冀,张睿苏,高彦宇,等.半枝莲含药血清对人卵巢癌SKOV3细胞增殖的影响［J］.中医药信息,2016,33(3):1-4.
［12］Jin X, Zhang Y, Zhang Z, et al. Juglone loaded poloxamer 188/phospholipid mixed micelles evaluated in vitro and in vivo in breast cancer［J］. Int J Pharm, 2016, 515(1/2):359-366.
［13］Peng X, Nie Y, Wu J, et al. Juglone prevents metabolic endotoxemia-induced hepatitis and neuroinflammation via suppressing TLR4/NF-κB signaling pathway in high-fat diet rats［J］. Biochem Biophys Res Commun, 2015, 462(3):245-250.
［14］李岩,赵剑璞,王燕妮,等.胡桃醌含药血清体外抗肿瘤实验研究［J］.北京理工大学学报,2013,33(5):545-550.
［15］董文婷,霍金海,张海燕,等. 干、鲜北青龙衣中胡桃醌的含量及抗肿瘤活性比较［J］.吉林中医药,2016,36(4):401-404.
［16］方芳,郝峰,李强,等. 胡桃醌抑制卵巢癌SKOV3细胞黏附和侵袭作用［J］.中国公共卫生,2015,31(9):1159-1161.
［17］赵行宇,杨森,周丽霞,等. 胡桃醌对肝癌HepG2细胞的增殖抑制及诱导凋亡作用［J］.吉林大学学报（医学版）,2013,39(2):255-258.
［18］Peng H, Wang Q, Qi X, et al. Orlistat induces apoptosis and protective autophagy in ovarian cancer cells: involvement of Akt-mTOR-mediated signaling pathway［J］. Arch Gynecol Obstet, 2018, 298(3):597-605.
［19］王博,邵美丽,刘星,等.miR-148 a下调Livin促进卵巢癌OVCAR-3细胞的凋亡［J］.疑难病杂志,2018,17(9):927-931.
［20］Hua F, Li CH, Chen XG. Daidzein exerts anticancer activity towards SKOV3 human ovarian cancer cells by inducing apoptosis and cell cycle arrest, and inhibiting the Raf/MEK/ERK cascade［J］. Int J Mol Med, 2018,41(6):3485-3492.
［21］Yang J, Li G. Pro-survival effects by NF-κB, Akt and ERK(1/2) and anti-apoptosis actions by Six1 disrupt apoptotic functions of TRAIL-Dr4/5 pathway in ovarian cancer［J］. Biomed Pharmacother, 2016, 84(12):1078-1087.
［22］Han X, Zhou Y, You Y, et al.TET1 promotes cisplatin-resistance via demethylating the vimentin promoter in ovarian cancer［J］.Cell Biol Int,2017,41(4):405-414.
［23］Sun X, Lin L, Chen Y, et al. Nitidine chloride inhibits ovarian cancer cell migration and invasion by suppressing MMP-2/9 production via the ERK signaling pathway［J］. Mol Med Rep, 2016,13(4):3161-3168.
［24］赵行宇,侯建成,金连海,等. 胡桃醌对人宫颈癌HeLa细胞侵袭与迁移的影响［J］.解剖学报,2017,48(2):160-164.

[1]	秦文秀, 许军峰, 杨婷, 王坪霏. 丹参酮IIA治疗缺血性脑卒中后神经损伤的信号通路研究进展[J]. 中国临床药理学与治疗学, 2023, 28(6): 705-713.
[2]	王艳, 张金辉, 赵永辰, 刘宏祥, 刘亚维, 苗欢欢, 杨信才. 红杉黄酮通过下调PI3K/AKT信号通路抑制胃癌细胞增殖侵袭等干细胞特性[J]. 中国临床药理学与治疗学, 2023, 28(5): 508-513.
[3]	侯瑞英, 郭莉阁, 焦伟杰, 杜蕾, 吴桂月, 赵旭. 消渴舒方对2型糖尿病模型大鼠血清炎症因子的影响及其机制研究[J]. 中国临床药理学与治疗学, 2023, 28(4): 377-382.
[4]	李若柠, 郭展立, 王媛, 孙建军. 血小板内皮聚集受体1及其介导的信号通路在血小板和内皮细胞中的作用研究进展[J]. 中国临床药理学与治疗学, 2023, 28(4): 438-444.
[5]	侯小煜, 冷玉芳, 曹雪芬, 吕兴娇, 韩晓霞, Janvier NIBARUTA, 刘永强. 五味子乙素减轻小鼠肠缺血再灌注损伤的网络药理学分析及实验验证[J]. 中国临床药理学与治疗学, 2023, 28(2): 147-154.
[6]	朱瑞芳, 郭东凯, 智慧, 江翊国, 张悦翎, 钱晓萍, 季士亮. ROS-NF-κB-p38MAPK通路探索榄香烯联合硼替佐米抗多发性骨髓瘤的机制研究[J]. 中国临床药理学与治疗学, 2023, 28(11): 1219-1226.
[7]	李菲, 丁慧琴, 陈梦静. 异莲心碱激活ERK信号通路诱导肺癌PC9细胞自噬的作用研究[J]. 中国临床药理学与治疗学, 2023, 28(11): 1235-1240.
[8]	陈玉林, 蒋虎刚, 王新强, 刘凯, 李应东, 安涛, 赵信科. 基于网络药理学和分子对接探讨芪参益心颗粒治疗射血分数保留型心力衰竭的作用机制[J]. 中国临床药理学与治疗学, 2023, 28(10): 1081-1092.
[9]	黄会珍, 韩磊, 林晓冬, 陈磊. 胰腺炎发病机制相关信号通路研究进展[J]. 中国临床药理学与治疗学, 2023, 28(1): 109-113.
[10]	周欢, 徐铭, 李波, 刘春英, 王淳. PI3K/Akt/FOXO3a信号通路介导的保护性自噬参与肺腺癌获得性顺铂耐药表型重塑[J]. 中国临床药理学与治疗学, 2022, 27(9): 961-970.
[11]	丁嘉敏, 王友娣, 赵夏丽, 姜根风, 陈思文, 洪程程, 李书勤, 胡卫华. 生长激素和维生素E联合应用治疗薄型子宫内膜的研究[J]. 中国临床药理学与治疗学, 2022, 27(8): 857-862.
[12]	眭玉霞, 庄捷, 庄敏, 黄桂. Delicaflavone通过PI3K/AKT/mTOR通路调控上皮-间质转化抑制吉非替尼耐药肺癌PC-9/GR细胞迁移和侵袭[J]. 中国临床药理学与治疗学, 2022, 27(6): 614-621.
[13]	姚倩, 陈赟, 商娟, 袭晓昀, 陈影, 顾潇, 居文政, 邹建东, 卢苏, 许美娟. 基于HPLC-Q-TOF/MS和网络药理学的清心滋肾方防治绝经综合征潜在药效物质基础和作用机制研究[J]. 中国临床药理学与治疗学, 2022, 27(5): 481-497.
[14]	王新丽, 许霞青, 方寒冰, 郭玉忠. 佛波酯增强顺铂的抗肿瘤活性及降低其肾毒性的作用研究[J]. 中国临床药理学与治疗学, 2022, 27(5): 535-543.
[15]	施经斌, 熊阳. 肿瘤微环境与乳腺癌细胞互作导致肿瘤转移的研究进展[J]. 中国临床药理学与治疗学, 2022, 27(5): 562-574.